Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Kute

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Seminars in Oncology|June 1, 1985
Dose-related pharmacologic effects of high-dose ara-C and its self-potentiationR L Capizzi, J L Yang, J P Rathmell, et al.
Nature|January 2, 1997
Potent antitumour activity of a new class of tumour-specific killer cellsS Y Chen, A G Yang, J D Chen, et al.
AIDS Research and Human Retroviruses|June 1, 1995
Membrane-interactive phospholipids inhibit HIV type 1-induced cell fusion and surface gp160/gp120 binding to monoclonal antibodyL Krugner-Higby, D Goff, T Edwards, et al.
Cancer Research|September 25, 1992
IGFBP-3 gene expression and estrogen receptor status in human breast carcinomaZ M Shao, M S Sheikh, J V Ordonez, et al.
The New England Journal of Medicine|May 5, 1994
c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancerH B Muss, A D Thor, D A Berry, et al.
Journal of the National Cancer Institute|September 25, 1998
erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancerA D Thor, D A Berry, D R Budman, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Seminars in Oncology|June 1, 1985
Dose-related pharmacologic effects of high-dose ara-C and its self-potentiationR L Capizzi, J L Yang, J P Rathmell, et al.
Nature|January 2, 1997
Potent antitumour activity of a new class of tumour-specific killer cellsS Y Chen, A G Yang, J D Chen, et al.
AIDS Research and Human Retroviruses|June 1, 1995
Membrane-interactive phospholipids inhibit HIV type 1-induced cell fusion and surface gp160/gp120 binding to monoclonal antibodyL Krugner-Higby, D Goff, T Edwards, et al.
Cancer Research|September 25, 1992
IGFBP-3 gene expression and estrogen receptor status in human breast carcinomaZ M Shao, M S Sheikh, J V Ordonez, et al.
The New England Journal of Medicine|May 5, 1994
c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancerH B Muss, A D Thor, D A Berry, et al.
Journal of the National Cancer Institute|September 25, 1998
erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancerA D Thor, D A Berry, D R Budman, et al.
Pageof 2